Compare Globus Medical Inc. Class A Common Stock (GMED) vs Teradyne, Inc. (TER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Teradyne, Inc. — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.99 (market cap $10.25B), while Teradyne, Inc. trades at $344.44 (market cap $56.20B). The key difference: Teradyne, Inc. is far larger — about 5.5× Globus Medical Inc. Class A Common Stock's market cap, and Teradyne, Inc. pays a 0.14% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Teradyne, Inc. for 37 Days on average.
| GMED | TER | |
|---|---|---|
Market Cap | $10.25B | $56.20B |
Volume | 1,059,528 | 3,754,298 |
Sector | Health | Technology |
52-Week High | $96.82 | $483.84 |
52-Week Low | $58.33 | $138.09 |
Typical Hold Time | 0 Days | 37 Days |
Enterprise Value | $9.76B | $55.94B |
Dividend Yield | — | 0.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Teradyne (TER) trades at $380.29, down 0.93% on the day, with a bearish technical signal and support near $378. The stock shows strong fundamentals, beating earnings estimates in recent quarters, with a 25.77% net income margin and robust ROE of 36.66%. Recent news highlights expansion in AI-driven memory test solutions and strategic partnerships, positioning the company for growth in semiconductor equipment demand.
Outlook is positive with analyst consensus price target of $461.50, implying 21% upside, supported by 61% buy ratings. Risks include competitive pressures in semiconductor testing and reliance on cyclical tech spending. Earnings momentum and AI-driven demand present opportunities, but investors should monitor execution against high valuation multiples like a P/E of 52.24.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Teradyne, Inc.
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Read more on TER →
